06:52 AM EDT, 10/14/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Tuesday it plans to separate its orthopedics business into a standalone company operating as DePuy Synthes.

The separation, which is expected to be completed within 18 to 24 months, will create the world's largest orthopedics-focused company, it said.

Namal Nawana has named president of DePuy Synthes. He was previously with a privately held consumer diagnostics firm, according to Johnson & Johnson ( JNJ ). The board and regulators still need to approve the separation, the company said.